Results 161 to 168 of about 578 (168)
Some of the next articles are maybe not open access.

Survey on the safety of a no-updosing regimen of sublingual immunotherapy.

European annals of allergy and clinical immunology, 2006
Musarra A   +3 more
openaire   +2 more sources

Peanut Oral Immunotherapy Updosing via In-Office, Video, and Telephone Encounters: Safety and Caregiver Satisfaction.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Peanut oral immunotherapy (POIT) in infants and toddlers is highly efficacious and can facilitate ad lib peanut consumption. However, traditional protocols require all updosing to occur in the office setting, creating logistical barriers for both families and allergy/immunology practices.To evaluate caregiver satisfaction and safety of POIT with home ...
S Shahzad, Mustafa   +5 more
openaire   +1 more source

Bilastine: A New H1-Antihistamine With an Optimal Profile for Updosing in Urticaria

Journal of the European Academy of Dermatology and Venereology, 2017
Martin Church, M K Church
exaly  

Peanut oral immunotherapy updosing via in-office, video, and telephone encounters

Annals of Allergy, Asthma & Immunology
S. Shahzad Mustafa   +5 more
openaire   +1 more source

Fraction of Exhaled Nitric Oxide (FeNO) As A Predictor Of GI Symptoms During Food Allergen Updosing

Journal of Allergy and Clinical Immunology, 2017
Madeleine B. Chollet   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy